Professional Documents
Culture Documents
665-Article Text-664-1-10-20171128
665-Article Text-664-1-10-20171128
ปี ที� �� ฉบับที� � มีนาคม - เมษายน ���� Vol. 23 No. 2 March - April 2014
ข้อเสนอแนะ
198 Journal of Health Science 2014 Vol. 23 No. 2
การกระจายตัวของ HLA-B อัลลีล ในตัวอย่างจาก โครงการสํารวจสุขภาพประชาชนไทยครั�งที� �
อั ล ลี ลของ HLA-B ที� พบบ่ อยในประเทศไทยมี 6. Chantarangsu S, Mushiroda T, Mahasirimongkol S,
ความแตกต่ า งกั น ระหว่ า งภู มิ ภ าคอยู่ บ้ าง แต่ ความ Kiertiburanakul S, Sungkanuparph S, Manosuthi W, et
แตกต่างนี� ไม่มีผลต่อการตัดสินใจทางนโนบายสํา หรับ al. HLA-B*35:05 allele is a strong predictor for
nevirapine-induced skin adverse drug reactions in HIV-
การตรวจ HLA-B*15:02, HLA-B*58:01, HLA-
infected Thai patients. Pharmacogenet Genomics
B*57:01 และ HLA-B*35:05 2009;19:139-46.
7. Hung SI, Chung WH, Chen YT. Genetics of severe drug
กิตติกรรมประกาศ hypersensitivity reactions in Han Chinese. In: Phichler
งานวิจยั นี�ได้รบั ทุนสนับสนุนจากกรมวิทยาศาสตร์- WJ, editor. Drug Hypersensitivity. Basel: Karger; 2007.
การแพทย์ กระทรวงสาธารณสุข p. 55-64.
8. Romphruk AV, Rompruk A, Kongmaroeng C,
Klumkrathok K, Paupairoj C, Leelayuwat C. HLA class
เอกสารอ้างอิง I and II alleles and haplotypes in ethnic Northeast Thais.
1. Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z,
Tissue Antigens 2010;75:701-11.
Bharadwaj M, et al. Immune self-reactivity triggered by
9. Kupatawintu P, Pheancharoen S, Srisuddee A, Tanaka
drug-modified HLA-peptide repertoire. Nature
H, Tadokoro K, Nathalang O. HLA-A, -B, -DR hap-
2012;486:554-8.
lotype frequencies in the Thai stem cell donor registry.
2. Hung SI, Chung WH, Chen YT. HLA-B genotyping to
Tissue Antigens 2010;75:730-6.
detect carbamazepine-induced Stevens-Johnson syn-
10. Man CBL, Kwan P, Baum L, Yu E, Lau KM, Chen
drome: Implications for personalizing Medicine. Per-
ASH, et al. Association between HLA-B*15:02 allele
sonalized Med 2005; 2: 225-37.
and antiepileptic drug-induced cutaneous reactions in
3. Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang
Han Chinese. Epilepsia 2007;48:1015-8.
HP, et al. HLA-B*58:01 allele as a genetic marker for
11. Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Chen
severe cutaneous adverse reactions caused by allopu-
P, Lin SY, Chen WH, et al. Association between HLA-
rinol. Proc Natl Acad Sci USA 2005;102:4134-9.
B*15:02 and carbamazepine-induced severe cutaneous
4. Tassaneeyakul W, Jantararoungtong T, Chen Pei, Lin
adverse drug reactions in Thai population. Epilepsia
PY, Tiamkao S, Khunarkornsiri U, et al. Strong asso-
2010;51:926-30.
ciation between HLA-B*58:01 and allopurinol-induced
12. Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, et
Stevens-Johnson syndrome and toxic epidermal necrolysis
al. Carbamazepine-induced toxic effects and HLA-
in a Thai population. Pharmacogenet Genomics
B*15:02 screening in Taiwan. N Engl J Med
2009;19:704-9.
2011;364:1126-33.
5. Mallal S, Phillips E, Carosi G, Molina JM, Workman C,
Tomazic J, et al. HLA-B*57:01 screening for hyper-
sensitivity to abacavir. N Engl J Med 2008;358:568-
79.
Abstract: HLA-B Allelic Distribution in Samples from Thailand National Health Examination Survey
Surakameth Mahasirimongkol, M.D., M.S. (Genetic Epidemiology), Ph.D. (Human Genetics)*; Chayapol
Somboonyosdech, B.S. (Biotechnology), M.S. (Pharmavology)*; Sanit Kumperasart, B.Ed (General
Sciences)*; Sukanya Wattanapokayakit, B.S. (Biology), M.P.H. (Public Health Administration)*; Nusara
Satproedprai, B.S. (Medical Technology), Ph.D. (Microbiology and Immunology)*; Wimala Inunchot,
B.S. (Applied Biology)*; Wichai Aekplakorn, M.D., Ph.D. (Epidemiology)**; Nuanjun Wichukchinda,
B.S. (Medical Technology), M.S. (Clinical Pathology), Ph.D. (Medical Sciences)*
*Medical Genetics Center, Medical Life Science Institute, Department of Medical Sciences, Ministry of
Public Health; **Department of Community Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol
University
Journal of Health Science 2014;23:191-200.
HLA-B allele is a clinically relevant genetic marker in pharmacogenomics. Carrier status of at
risk allele is useful information for avoidance of serious cutaneous adverse reactions. Therefore infor-
mation of regional allelic distribution of HLA-B in Thailand is essential for consideration processes for
adoption of the genetic testing to avoid drug induced severe cutaneous adverse reaction (SCAR),
including Steven Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). This study reported the
distribution of HLA-B alleles in 650 samples, which were randomly sampled from the 3rd Thailand
National Health Examination Survey to represent population of 4 regions and the capital city, Bangkok.
It was found that the HLA-B *15:02 allele, associated with carbamazepine induced of SJS/TEN, was
detected at highest prevalence in Bangkok (10.00%) and the southern region (9.50%). The frequency
of HLA-B*15:02 allele in northeast, north, and central were 7.33%, 8.39% and 9.25%, respectively.
The HLA-B*58:01, associated with allopurinol induced SJS/TEN was the most frequent allele found
in the northeast area (9.00%) and Bangkok (9.00%) but its frequency was low in the northern
(6.38%), central (5.00%) and southern area (4.50%). In contrast, the HLA-B*35:05 allele, asso-
ciated with nevirapine induced rash, was most commonly found in the southern area (4.00%) and less
common in the northeast (3.33%), central (2.25%), Bangkok (2.00%) and northern areas (0.67%).
These results indicated that the distributions of HLA-B alleles are different in each region of Thailand,
which may depend on the pattern of ancestral migration. The data on the distribution of HLA-B alleles
from major geographic regions of Thailand are useful information for policy adoption of pharmacogenomics
testing services in Thailand.
Key words: HLA-B allele, Thai population, pharmacogenomics, severe cutaneous adverse reaction